Cargando…

RNAMethyPro: a biologically conserved signature of N6-methyladenosine regulators for predicting survival at pan-cancer level

Accumulating evidence indicates the role of N(6)-methyladenosine (m(6)A) regulator-mediated RNA methylation in cancer progression and metastasis; yet its potential clinical significance, if any, remains unclear. In this first-of-its-kind study, we systematically evaluated the role of m(6)A regulator...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kandimalla, Raju, Gao, Feng, Li, Ying, Huang, Hao, Ke, Jia, Deng, Xin, Zhao, Linjie, Zhou, Shengtao, Goel, Ajay, Wang, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494854/ https://www.ncbi.nlm.nih.gov/pubmed/31069256 http://dx.doi.org/10.1038/s41698-019-0085-2

Ejemplares similares

Integrative network biology analysis identifies miR-508-3p as the determinant for the mesenchymal identity and a strong prognostic biomarker of ovarian cancer
por: Zhao, Linjie, et al.
Publicado: (2018)

Correction: Integrative network biology analysis identifies miR-508-3p as the determinant for the mesenchymal identity and a strong prognostic biomarker of ovarian cancer
por: Zhao, Linjie, et al.
Publicado: (2019)

A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer
por: Okuno, Keisuke, et al.
Publicado: (2023)

Regulatory Role of RNA N(6)-Methyladenosine Modification in Bone Biology and Osteoporosis
por: Chen, Xuejiao, et al.
Publicado: (2020)

Evolutionary conservation of the DRACH signatures of potential N6-methyladenosine (m(6)A) sites among influenza A viruses
por: Bayoumi, Mahmoud, et al.
Publicado: (2021)

N6-Methyladenosine Modification Opens a New Chapter in Circular RNA Biology
por: Wu, Jun, et al.
Publicado: (2021)

Pan-Cancer Analysis of the N6-Methyladenosine Eraser FTO as a Potential Prognostic and Immunological Biomarker
por: Zhao, Chengwen, et al.
Publicado: (2021)

ProPan: a comprehensive database for profiling prokaryotic pan-genome dynamics
por: Zhang, Yadong, et al.
Publicado: (2022)

Widespread occurrence of N(6)-methyladenosine in bacterial mRNA
por: Deng, Xin, et al.
Publicado: (2015)

N(6)-Methyladenosine and Viral Infection
por: Dang, Wei, et al.
Publicado: (2019)

The reverse transcription signature of N-1-methyladenosine in RNA-Seq is sequence dependent
por: Hauenschild, Ralf, et al.
Publicado: (2015)

Construction and validation of an N6-methyladenosine-associated prognostic signature in hepatocellular carcinoma
por: Zhu, Peng, et al.
Publicado: (2021)

Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes
por: Luo, Zhenhua, et al.
Publicado: (2019)

Pan-cancer analysis of tissue and single-cell HIF-pathway activation using a conserved gene signature
por: Lombardi, Olivia, et al.
Publicado: (2022)

Pan-Cancer Molecular Patterns and Biological Implications Associated with a Tumor-Specific Molecular Signature
por: Rocha, Darío, et al.
Publicado: (2020)

Establishment of Prognostic Signatures of N6-Methyladenosine-Related lncRNAs and Their Potential Functions in Hepatocellular Carcinoma Patients
por: Wu, Xianbin, et al.
Publicado: (2022)

Deciphering N(6)-Methyladenosine-Related Genes Signature to Predict Survival in Lung Adenocarcinoma
por: Zhu, Jie, et al.
Publicado: (2020)

Gene Signatures and Prognostic Values of N6-Methyladenosine Related Genes in Ovarian Cancer
por: Na, Zhijing, et al.
Publicado: (2021)

Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma
por: Chen, Yujia, et al.
Publicado: (2022)

RNA N(6)-methyladenosine modification in female reproductive biology and pathophysiology
por: Huang, Erqing, et al.
Publicado: (2023)

The pan‐genome of the cultivated soybean (PanSoy) reveals an extraordinarily conserved gene content
por: Torkamaneh, Davoud, et al.
Publicado: (2021)

Connecting N6‐methyladenosine modification to ferroptosis resistance in hepatoblastoma
por: Peng, Wan‐Xin, et al.
Publicado: (2022)

The role of RNA N(6)-methyladenosine methyltransferase in cancers
por: Huang, Jiali, et al.
Publicado: (2021)

Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer
por: Chen, Pin, et al.
Publicado: (2023)

RNA N1-methyladenosine regulator-mediated methylation modification patterns and heterogeneous signatures in glioma
por: Mao, Meng, et al.
Publicado: (2022)

N(1)-methyladenosine modification in cancer biology: Current status and future perspectives
por: Li, Jiexin, et al.
Publicado: (2022)

Clinical and biological significance of RNA N6-methyladenosine regulators in Alzheimer disease
por: Qiu, Zhiqiang, et al.
Publicado: (2023)

Genomic, epigenomic, and transcriptomic signatures for telomerase complex components: a pan‐cancer analysis
por: Wang, Jing, et al.
Publicado: (2022)

Evolution of transcript modification by N(6)-methyladenosine in primates
por: Ma, Lijia, et al.
Publicado: (2017)

The Roles of N6-Methyladenosine Modification in Plant–RNA Virus Interactions
por: He, Min, et al.
Publicado: (2023)

N6-methyladenosine associated prognostic model in hepatocellular carcinoma
por: Huang, Hanchun, et al.
Publicado: (2020)

Pan-Cancer Prognostic, Immunity, Stemness, and Anticancer Drug Sensitivity Characterization of N6-Methyladenosine RNA Modification Regulators in Human Cancers
por: Li, Rui, et al.
Publicado: (2021)

Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations
por: Brady, Samuel W., et al.
Publicado: (2020)

Comprehensive Analysis of N6-Methyladenosine-Related lncRNA Signature for Predicting Prognosis and Immune Cell Infiltration in Patients with Colorectal Cancer
por: Zhao, Zhan, et al.
Publicado: (2021)

Identification and Validation of N6-Methyladenosine-Related Biomarkers for Bladder Cancer: Implications for Immunotherapy
por: Deng, Hongyu, et al.
Publicado: (2022)

Integrative Analysis of Hypoxia-Associated Signature in Pan-Cancer
por: Zhang, Qian, et al.
Publicado: (2020)

N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients
por: Song, Wei, et al.
Publicado: (2021)

Development and Validation of a Prognostic N6-Methyladenosine-Related Immune Gene Signature for Lung Adenocarcinoma
por: Zhang, Lemeng, et al.
Publicado: (2021)

Effect of N6-methyladenosine methylation-related gene signature for predicting the prognosis of hepatocellular carcinoma patients
por: Zheng, Xinyu, et al.
Publicado: (2023)

The RNA N6-Methyladenosine Methyltransferase METTL3 Promotes the Progression of Kidney Cancer via N6-Methyladenosine-Dependent Translational Enhancement of ABCD1
por: Shi, Yue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kfsm44vrv63vehk1pg6kp1inb4